Stock / equity
ELV Elevance Health, Inc.
- Company
- Elevance Health, Inc.
- Security
- Equity
- Size, estimated from filings
- Large cap ($10B – $200B)
- Insiders on record
- 10
- Members of Congress
- 2
- Latest trade on record
- October 2, 2026
ELV (Elevance Health, Inc.) has 18 disclosed insider transactions from 10 insiders in the last 12 months (3 open-market buys, 7 sales, about $4.5M at reported prices) and 2 congressional trades from 2 members of Congress. The most recent disclosure was filed October 6, 2026.
Share price
Price and chart by TradingView for Elevance Health, Inc.. US share prices here are delayed, not real-time. The trade records on this page come from government filings, not from this chart.
ELV in charts
Who is trading this stock
Which people account for the buying and selling over the last 12 months?
8 people account for the disclosed buying and selling in ELV over the last 12 months; the most active is Kaye Mark with $1.6M.
Prices insiders traded at
What price did insiders buy and sell at? Each marker is one open-market trade at the share price reported on its Form 4.
Insiders reported 6 open-market trades in ELV since May 19, 2026, at prices from $366 to $403; the most recent was a purchase at $366 on Jul 17, 2026. These are the prices on the filings, not adjusted for stock splits, and not a market price series.
Insider holdings over time
Is an insider building or unwinding a position? Shares held directly after each filing.
Penczek Ronald W reported 3,740 shares held after the latest filing, against 4,109 at the first on record.
Lobbying spend by quarter
How much has Elevance Health, Inc. reported spending on federal lobbying?
Elevance Health, Inc. reported $9.4M in lobbying over the last eight quarters, from filings matched by exact company name.
Insiders trading ELV
Everyone who filed a Form 4 for this ticker, by number of rows on record. "Bought" and "sold" count open-market purchases (code P) and sales only; awards, option exercises and shares withheld for tax are in the row count but not in those two columns.
| Insider | Role | Rows | Bought | Sold | Value bought | Value sold | Latest |
|---|---|---|---|---|---|---|---|
| Penczek Ronald W | CAO & Controller | 6 | 0 | 2 | — | $766K | June 12, 2026 |
| Kaye Mark | EVP & CFO | 2 | 0 | 1 | — | $1.6M | October 2, 2026 |
| Wessling Erin M | EVP & Chief Legal Officer | 2 | 0 | 2 | — | $144K | September 3, 2026 |
| BOUDREAUX GAIL | Director | 2 | 2 | 0 | $1.0M | — | July 17, 2026 |
| Craig Ryan R | EVP & Chief HR Officer | 1 | 0 | 1 | — | $58K | September 2, 2026 |
| PERU RAMIRO G | Director | 1 | 1 | 0 | $366K | — | July 17, 2026 |
| Dixon Robert L JR | Director | 1 | 0 | 1 | — | $61K | June 11, 2026 |
| Schneider Ryan M. | Director | 1 | 0 | 0 | — | — | May 13, 2026 |
| SCHULMAN AMY W | Director | 1 | 0 | 0 | — | — | May 13, 2026 |
| STRABLE-SOETHOUT DEANNA D | President and CEO | 1 | 0 | 0 | — | — | May 13, 2026 |
What kind of transactions these are 5 Form 4 codes
| Code | Meaning | Rows | Shares | Value at reported prices |
|---|---|---|---|---|
| A | Grant or award | 4 | 4,316 | — |
| F | Shares withheld for tax | 4 | 4,654 | $1.8M |
| M | Option exercise or conversion | 4 | 3,062 | $451K |
| P | Open-market purchase | 3 | 3,725 | $1.4M |
| S | Open-market sale | 3 | 2,051 | $827K |
What each code means: Form 4 transaction codes.
Members of Congress trading ELV
Members whose periodic transaction reports name this ticker. Amounts are the sums of the ranges as filed.
| Member | Seat | Trades | Bought | Sold | Range as filed | Latest |
|---|---|---|---|---|---|---|
| Alan Armstrong | Senator (OK), Republican | 1 | 1 | 0 | $1,001–$15K | March 27, 2026 |
| Markwayne Mullin | Senator (OK), Republican | 1 | 1 | 0 | $15K–$50K | December 29, 2025 |
Insider transactions
| Filer | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| Kaye Mark | Other A | October 2, 2026 | October 6, 2026 | 4d | 2,627 | — | — | Form 4 ↗ | ||
| Kaye Mark | Sell F | October 2, 2026 | October 6, 2026 | 4d | 4,161 | $386 | $1.6M | Form 4 ↗ | ||
| Craig Ryan R | Sell F | September 2, 2026 | September 4, 2026 | 2d | 144 | $406 | $58K | Form 4 ↗ | ||
| Wessling Erin M | Sell F | September 3, 2026 | September 4, 2026 | 1d | 255 | $415 | $106K | Form 4 ↗ | ||
| Wessling Erin M | Sell F | September 2, 2026 | September 4, 2026 | 2d | 94 | $406 | $38K | Form 4 ↗ | ||
| BOUDREAUX GAIL | Buy P | July 17, 2026 | July 17, 2026 | 0d | 2,045 | $368 | $753K | Form 4 ↗ | ||
| BOUDREAUX GAIL | Buy P | July 17, 2026 | July 17, 2026 | 0d | 680 | $366 | $249K | Form 4 ↗ | ||
| PERU RAMIRO G | Buy P | July 17, 2026 | July 17, 2026 | 0d | 1,000 | $366 | $366K | Form 4 ↗ | ||
| Penczek Ronald W | Sell S | June 12, 2026 | June 15, 2026 | 3d | 369 | $403 | $149K | Form 4 ↗ | ||
| Dixon Robert L JR | Sell S | June 11, 2026 | June 12, 2026 | 1d | 151 | $402 | $61K | Form 4 ↗ | ||
| Penczek Ronald W | Option / conversion M | May 19, 2026 | May 20, 2026 | 1d | 877 | — | — | derivative | Form 4 ↗ | |
| Penczek Ronald W | Option / conversion M | May 19, 2026 | May 20, 2026 | 1d | 654 | — | — | derivative | Form 4 ↗ | |
| Penczek Ronald W | Sell S | May 19, 2026 | May 20, 2026 | 1d | 1,531 | $403 | $617K | Form 4 ↗ | ||
| Penczek Ronald W | Option / conversion M | May 19, 2026 | May 20, 2026 | 1d | 877 | $311 | $273K | Form 4 ↗ | ||
| Penczek Ronald W | Option / conversion M | May 19, 2026 | May 20, 2026 | 1d | 654 | $271 | $177K | Form 4 ↗ | ||
| Schneider Ryan M. | Other A | May 13, 2026 | May 15, 2026 | 2d | 563 | — | — | Form 4 ↗ | ||
| SCHULMAN AMY W | Other A | May 13, 2026 | May 15, 2026 | 2d | 563 | — | — | Form 4 ↗ | ||
| STRABLE-SOETHOUT DEANNA D | Other A | May 13, 2026 | May 15, 2026 | 2d | 563 | — | — | Form 4 ↗ |
Congressional trades
| Filer | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| Alan Armstrong | Buy | March 27, 2026 | July 21, 2026 | 116d | — | — | $1,001–$15K | late | Senate PTR ↗ | |
| Markwayne Mullin | Buy | December 29, 2025 | January 16, 2026 | 18d | — | — | $15K–$50K | joint | Senate PTR ↗ |
Related stocks
Tickers traded by the same people who traded ELV, by number of filers in common. It shows overlap in public filings and nothing else.
- DELL Dell Technologies Inc. Class C Common Stock 2 filers in common
- META Meta Platforms, Inc. - Class A Common Stock 2 filers in common
- INTU Intuit Inc. - Common Stock 2 filers in common
- ADBE Adobe Inc. - Common Stock 2 filers in common
- CRM Salesforce, Inc. Common Stock 2 filers in common
- LLY Eli Lilly and Company Common Stock 2 filers in common
- NOW ServiceNow, Inc. Common Stock 2 filers in common
- NVDA NVIDIA Corporation - Common Stock 2 filers in common
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- How to read a congressional trade report Owner tells you whose asset it was: the member, the spouse, a dependent child, or held jointly.
- Why congressional trade amounts are ranges There are ten ranges; the lowest is $1,001–$15,000 and the highest is over $50,000,000.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| Senate eFD, periodic transaction reports | 2 | 2 | January 16, 2026 | July 21, 2026 | Senate eFD search |
| SEC EDGAR, Form 4 | 11 | 18 | May 15, 2026 | October 6, 2026 | Form 4 list on EDGAR |
Site built October 22, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Insider rows are Form 4 filings for this issuer from SEC EDGAR; congressional rows are periodic transaction reports parsed from the House Clerk and the Senate eFD. Values use the reported price for Form 4 and the disclosed range for Congress. See methodology and corrections.
Not investment advice. Disclosures are shown as filed and may lag the trade or be amended. No recommendation is made or implied.